Global Immuno-Oncology Treatment Market Insight 2020, Forecast to 2025
The report requires updating with new data and is sent in 48 hours after order is placed.
The Immuno-Oncology Treatment market was valued at US$ xx in 2019, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Immuno-Oncology Treatment is projected to grow from US$ xx million in 2020, and is projected to reach xx by 2025, at a CAGR of xx% during the forecast period. Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation. Product values are estimated based on manufacturers' revenue.
The report offers detailed coverage of Immuno-Oncology Treatment industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Immuno-Oncology Treatment by geography. The report splits the market size, by volume and value, on the basis of application type and geography.
In addition to this data, the report provides insight into drivers of market demand and strategies of suppliers. Key players are profiled, and their market shares in the global Immuno-Oncology Treatment market are discussed.
The market is segmented by types:
Finally, the report provides detailed profile and data information analysis of leading company.
The Immuno-Oncology Treatment market was valued at US$ xx in 2019, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Immuno-Oncology Treatment is projected to grow from US$ xx million in 2020, and is projected to reach xx by 2025, at a CAGR of xx% during the forecast period. Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation. Product values are estimated based on manufacturers' revenue.
The report offers detailed coverage of Immuno-Oncology Treatment industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Immuno-Oncology Treatment by geography. The report splits the market size, by volume and value, on the basis of application type and geography.
In addition to this data, the report provides insight into drivers of market demand and strategies of suppliers. Key players are profiled, and their market shares in the global Immuno-Oncology Treatment market are discussed.
The market is segmented by types:
- Immune Checkpoint Inhibitors
- Monoclonal Antibodies
- Cytokine-Based Immunotherapy
- Cancer Vaccines
- CAR-T Cell Therapy
- Hospitals
- Ambulatory Surgical Center
- Others
Finally, the report provides detailed profile and data information analysis of leading company.
- Amgen
- AstraZeneca
- Bristol-Myers Squibb
- Eli-Lilly
- Roche
- GlaxoSmithKline
- Janssen Biotech
- Merck
- Novartis
- Pfizer
- Sanofi
- Spectrum Pharmaceuticals
- Takeda
- xx data tables and xx additional tables
- An overview of global Immuno-Oncology Treatment market
- An detailed key players analysis across regions
- Analyses of global market trends, with historical data, estimates for 2020 and projections of compound annual growth rates (CAGRs) through 2025
- Insights into regulatory and environmental developments
- Information on the supply and demand scenario and evaluation of technological and investment opportunities in the Immuno-Oncology Treatment market
- Profiles of major players in the industry, including Amgen, AstraZeneca, Bristol-Myers Squibb, Eli-Lilly, Roche.....
- To study and analyze the global Immuno-Oncology Treatment consumption (value & volume) by key regions/countries, product type and application, history data from 2015 to 2019, and forecast to 2025.
- To understand the structure of Immuno-Oncology Treatment market by identifying its various subsegments.
- Focuses on the key global Immuno-Oncology Treatment manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
- To analyze the Immuno-Oncology Treatment with respect to individual growth trends, future prospects, and their contribution to the total market.
- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
- To project the consumption of Immuno-Oncology Treatment submarkets, with respect to key regions (along with their respective key countries).
- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
- To strategically profile the key players and comprehensively analyze their growth strategies.
Global Immuno-Oncology Treatment Market Report 2020, Forecast to 2025
1 SCOPE OF THE STUDY
1.1 Immuno-Oncology Treatment Introduction
1.2 Research Programs
1.3 Analysis of Macroeconomic Indicators
1.4 Years Considered
1.5 Methodology
1.6 Data Source
1.7 Research Objectives
2 IMMUNO-ONCOLOGY TREATMENT INDUSTRY OVERVIEW
2.1 Global Immuno-Oncology Treatment Market Size (Million USD) Comparison by Regions (2020-2025)
2.1.1 Immuno-Oncology Treatment Global Main Region Market Analysis
2.2 Market Analysis by Type
2.2.1 Immune Checkpoint Inhibitors
2.2.2 Monoclonal Antibodies
2.2.3 Cytokine-Based Immunotherapy
2.2.4 Cancer Vaccines
2.2.5 CAR-T Cell Therapy
2.3 Market Analysis by Application
2.3.1 Hospitals
2.3.2 Ambulatory Surgical Center
2.3.3 Others
2.4 Global Immuno-Oncology Treatment Revenue, Sales and Market Share by Manufacturer
2.4.1 Global Immuno-Oncology Treatment Sales and Market Share by Manufacturer (2018-2020)
2.4.2 Global Immuno-Oncology Treatment Revenue and Market Share by Manufacturer (2018-2020)
2.4.3 Global Immuno-Oncology Treatment Industry Concentration Ratio (CR5 and HHI)
2.4.4 Top 5 Immuno-Oncology Treatment Manufacturer Market Share
2.4.5 Top 10 Immuno-Oncology Treatment Manufacturer Market Share
2.4.6 Date of Key Manufacturers Enter into Immuno-Oncology Treatment Market
2.4.7 Key Manufacturers Immuno-Oncology Treatment Product Offered
2.4.8 Mergers & Acquisitions Planning
2.5 Immuno-Oncology Treatment Historical Development Overview
2.6 Market Dynamics
2.6.1 Market Opportunities
2.6.2 Market Risk
2.6.3 Market Driving Force
2.6.4 Porter's Five Forces Analysis
2.7 Coronavirus Disease 2019 (Covid-19): Immuno-Oncology Treatment Industry Impact
2.7.1 How the Covid-19 is Affecting the Immuno-Oncology Treatment Industry
2.7.2 Immuno-Oncology Treatment Business Impact Assessment - Covid-19
2.7.3 Market Trends and Immuno-Oncology Treatment Potential Opportunities in the COVID-19 Landscape
2.7.4 Measures / Proposal against Covid-19
3 RELATED MARKET ANALYSIS
3.1 Related Market Overview
3.2 Macro Analysis of Upstream Markets
3.3 Key Players in Related Markets
3.4 Related Markets Trend Analysis
4 GLOBAL IMMUNO-ONCOLOGY TREATMENT MARKET SIZE CATEGORIZED BY REGIONS
4.1 Global Immuno-Oncology Treatment Revenue and Market Share by Regions
4.1.1 Global Immuno-Oncology Treatment Sales and Market Share by Regions (2015-2020)
4.1.2 Global Immuno-Oncology Treatment Revenue and Market Share by Regions (2015-2020)
4.2 Europe Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
4.3 APAC Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
4.4 North America Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
4.5 South America Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
5 EUROPE IMMUNO-ONCOLOGY TREATMENT MARKET SIZE CATEGORIZED BY COUNTRIES
5.1 Europe Immuno-Oncology Treatment Revenue and Market Share by Countries
5.1.1 Europe Immuno-Oncology Treatment Revenue by Countries (2015-2020)
5.1.2 Germany Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
5.1.3 UK Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
5.1.4 France Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
5.1.5 Russia Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
5.1.6 Italy Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
5.1.7 Spain Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
5.2 Europe Immuno-Oncology Treatment Revenue (Value) by Manufacturers (2018-2020)
5.3 Europe Immuno-Oncology Treatment Revenue and Market Share by Type (2015-2020)
5.4 Europe Immuno-Oncology Treatment Revenue and Market Share by Application (2015-2020)
6 ASIA-PACIFIC IMMUNO-ONCOLOGY TREATMENT MARKET SIZE CATEGORIZED BY COUNTRIES
6.1 Asia-Pacific Immuno-Oncology Treatment Revenue and Market Share by Countries
6.1.1 Asia-Pacific Immuno-Oncology Treatment Revenue by Countries (2015-2020)
6.1.2 China Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
6.1.3 Japan Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
6.1.4 Korea Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
6.1.5 India Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
6.1.6 Southeast Asia Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
6.1.7 Australia Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
6.2 Asia-Pacific Immuno-Oncology Treatment Revenue (Value) by Players (2018-2020)
6.3 Asia-Pacific Immuno-Oncology Treatment Revenue and Market Share by Type (2015-2020)
6.4 Asia-Pacific Immuno-Oncology Treatment Revenue and Market Share by Application (2015-2020)
7 NORTH AMERICA IMMUNO-ONCOLOGY TREATMENT MARKET SIZE CATEGORIZED BY COUNTRIES
7.1 North America Immuno-Oncology Treatment Revenue and Market Share by Countries
7.1.1 North America Immuno-Oncology Treatment Revenue by Countries (2015-2020)
7.1.2 United States Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
7.1.3 Canada Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
7.1.4 Mexico Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
7.2 North America Immuno-Oncology Treatment Revenue (Value) by Players (2018-2020)
7.3 North America Immuno-Oncology Treatment Revenue and Market Share by Type (2015-2020)
7.4 North America Immuno-Oncology Treatment Revenue and Market Share by Application (2015-2020)
8 SOUTH AMERICA IMMUNO-ONCOLOGY TREATMENT MARKET SIZE CATEGORIZED BY COUNTRIES
8.1 South America Immuno-Oncology Treatment Revenue and Market Share by Countries
8.1.1 South America Immuno-Oncology Treatment Revenue by Countries (2015-2020)
8.1.2 Brazil Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
8.2 South America Immuno-Oncology Treatment Revenue (Value) by Players (2018-2020)
8.3 South America Immuno-Oncology Treatment Revenue and Market Share by Type (2015-2020)
8.4 South America Immuno-Oncology Treatment Revenue and Market Share by Application (2015-2020)
9 MIDDLE EAST AND AFRICA IMMUNO-ONCOLOGY TREATMENT MARKET SIZE CATEGORIZED BY COUNTRIES
9.1 Middle East and Africa Immuno-Oncology Treatment Revenue and Market Share by Countries
9.1.1 Middle East and Africa Immuno-Oncology Treatment Revenue by Countries (2015-2020)
9.1.2 GCC Countries Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
9.1.3 Turkey Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
9.1.4 Egypt Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
9.1.5 South Africa Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
9.2 Middle East and Africa Immuno-Oncology Treatment Revenue (Value) by Players (2018-2020)
9.3 Middle East and Africa Immuno-Oncology Treatment Revenue and Market Share by Type (2015-2020)
9.4 Middle East and Africa Immuno-Oncology Treatment Revenue and Market Share by Application (2015-2020)
10 GLOBAL IMMUNO-ONCOLOGY TREATMENT MARKET SEGMENT BY TYPE
10.1 Global Immuno-Oncology Treatment Revenue and Market Share by Type (2015-2020)
10.2 Global Immuno-Oncology Treatment Market Forecast by Type (2020-2025)
10.3 Immune Checkpoint Inhibitors Revenue Growth Rate
10.4 Monoclonal Antibodies Revenue Growth Rate
10.5 Cytokine-Based Immunotherapy Revenue Growth Rate
10.6 Cancer Vaccines Revenue Growth Rate
10.7 CAR-T Cell Therapy Revenue Growth Rate
11 GLOBAL IMMUNO-ONCOLOGY TREATMENT MARKET SEGMENT BY APPLICATION
11.1 Global Immuno-Oncology Treatment Revenue Market Share by Application (2015-2020)
11.2 Global Immuno-Oncology Treatment Market Forecast by Application (2020-2025)
11.3 Hospitals Revenue Growth Rate (2015-2025)
11.4 Ambulatory Surgical Center Revenue Growth Rate (2015-2025)
11.5 Others Revenue Growth Rate (2015-2025)
12 MARKET FORECAST FOR IMMUNO-ONCOLOGY TREATMENT
12.1 Global Immuno-Oncology Treatment Market Size Forecast (2020-2025)
12.2 Immuno-Oncology Treatment Market Forecast by Regions (2020-2025)
12.3 Europe Immuno-Oncology Treatment Revenue Market Forecast (2020-2025)
12.4 APAC Immuno-Oncology Treatment Revenue Market Forecast (2020-2025)
12.5 North America Immuno-Oncology Treatment Revenue Market Forecast (2020-2025)
12.6 South America Immuno-Oncology Treatment Revenue Market Forecast (2020-2025)
12.7 Middle East & Africa Immuno-Oncology Treatment Revenue Market Forecast (2020-2025)
13 ANALYSIS OF IMMUNO-ONCOLOGY TREATMENT INDUSTRY KEY VENDORS
13.1 Amgen
13.1.1 Company Details
13.1.2 Product Information
13.1.3 Amgen Immuno-Oncology Treatment Revenue and Gross Margin (2018-2020)
13.1.4 Main Business Overview
13.1.5 Amgen News
13.2 AstraZeneca
13.2.1 Company Details
13.2.2 Product Information
13.2.3 AstraZeneca Immuno-Oncology Treatment Revenue and Gross Margin (2018-2020)
13.2.4 Main Business Overview
13.2.5 AstraZeneca News
13.3 Bristol-Myers Squibb
13.3.1 Company Details
13.3.2 Product Information
13.3.3 Bristol-Myers Squibb Immuno-Oncology Treatment Revenue and Gross Margin (2018-2020)
13.3.4 Main Business Overview
13.3.5 Bristol-Myers Squibb News
13.4 Eli-Lilly
13.4.1 Company Details
13.4.2 Product Information
13.4.3 Eli-Lilly Immuno-Oncology Treatment Revenue and Gross Margin (2018-2020)
13.4.4 Main Business Overview
13.4.5 Eli-Lilly News
13.5 Roche
13.5.1 Company Details
13.5.2 Product Information
13.5.3 Roche Immuno-Oncology Treatment Revenue and Gross Margin (2018-2020)
13.5.4 Main Business Overview
13.5.5 Roche News
13.6 GlaxoSmithKline
13.6.1 Company Details
13.6.2 Product Information
13.6.3 GlaxoSmithKline Immuno-Oncology Treatment Revenue and Gross Margin (2018-2020)
13.6.4 Main Business Overview
13.6.5 GlaxoSmithKline News
13.7 Janssen Biotech
13.7.1 Company Details
13.7.2 Product Information
13.7.3 Janssen Biotech Immuno-Oncology Treatment Revenue and Gross Margin (2018-2020)
13.7.4 Main Business Overview
13.7.5 Janssen Biotech News
13.8 Merck
13.8.1 Company Details
13.8.2 Product Information
13.8.3 Merck Immuno-Oncology Treatment Revenue and Gross Margin (2018-2020)
13.8.4 Main Business Overview
13.8.5 Merck News
13.9 Novartis
13.9.1 Company Details
13.9.2 Product Information
13.9.3 Novartis Immuno-Oncology Treatment Revenue and Gross Margin (2018-2020)
13.9.4 Main Business Overview
13.9.5 Novartis News
13.10 Pfizer
13.10.1 Company Details
13.10.2 Product Information
13.10.3 Pfizer Immuno-Oncology Treatment Revenue and Gross Margin (2018-2020)
13.10.4 Main Business Overview
13.10.5 Pfizer News
13.11 Sanofi
13.11.1 Company Details
13.11.2 Product Information
13.11.3 Sanofi Immuno-Oncology Treatment Revenue and Gross Margin (2018-2020)
13.11.4 Main Business Overview
13.11.5 Sanofi News
13.12 Spectrum Pharmaceuticals
13.12.1 Company Details
13.12.2 Product Information
13.12.3 Spectrum Pharmaceuticals Immuno-Oncology Treatment Revenue and Gross Margin (2018-2020)
13.12.4 Main Business Overview
13.12.5 Spectrum Pharmaceuticals News
13.13 Takeda
13.13.1 Company Details
13.13.2 Product Information
13.13.3 Takeda Immuno-Oncology Treatment Revenue and Gross Margin (2018-2020)
13.13.4 Main Business Overview
13.13.5 Takeda News
14 RESEARCH FINDINGS AND CONCLUSION
15 APPENDIX
1 SCOPE OF THE STUDY
1.1 Immuno-Oncology Treatment Introduction
1.2 Research Programs
1.3 Analysis of Macroeconomic Indicators
1.4 Years Considered
1.5 Methodology
1.6 Data Source
1.7 Research Objectives
2 IMMUNO-ONCOLOGY TREATMENT INDUSTRY OVERVIEW
2.1 Global Immuno-Oncology Treatment Market Size (Million USD) Comparison by Regions (2020-2025)
2.1.1 Immuno-Oncology Treatment Global Main Region Market Analysis
2.2 Market Analysis by Type
2.2.1 Immune Checkpoint Inhibitors
2.2.2 Monoclonal Antibodies
2.2.3 Cytokine-Based Immunotherapy
2.2.4 Cancer Vaccines
2.2.5 CAR-T Cell Therapy
2.3 Market Analysis by Application
2.3.1 Hospitals
2.3.2 Ambulatory Surgical Center
2.3.3 Others
2.4 Global Immuno-Oncology Treatment Revenue, Sales and Market Share by Manufacturer
2.4.1 Global Immuno-Oncology Treatment Sales and Market Share by Manufacturer (2018-2020)
2.4.2 Global Immuno-Oncology Treatment Revenue and Market Share by Manufacturer (2018-2020)
2.4.3 Global Immuno-Oncology Treatment Industry Concentration Ratio (CR5 and HHI)
2.4.4 Top 5 Immuno-Oncology Treatment Manufacturer Market Share
2.4.5 Top 10 Immuno-Oncology Treatment Manufacturer Market Share
2.4.6 Date of Key Manufacturers Enter into Immuno-Oncology Treatment Market
2.4.7 Key Manufacturers Immuno-Oncology Treatment Product Offered
2.4.8 Mergers & Acquisitions Planning
2.5 Immuno-Oncology Treatment Historical Development Overview
2.6 Market Dynamics
2.6.1 Market Opportunities
2.6.2 Market Risk
2.6.3 Market Driving Force
2.6.4 Porter's Five Forces Analysis
2.7 Coronavirus Disease 2019 (Covid-19): Immuno-Oncology Treatment Industry Impact
2.7.1 How the Covid-19 is Affecting the Immuno-Oncology Treatment Industry
2.7.2 Immuno-Oncology Treatment Business Impact Assessment - Covid-19
2.7.3 Market Trends and Immuno-Oncology Treatment Potential Opportunities in the COVID-19 Landscape
2.7.4 Measures / Proposal against Covid-19
3 RELATED MARKET ANALYSIS
3.1 Related Market Overview
3.2 Macro Analysis of Upstream Markets
3.3 Key Players in Related Markets
3.4 Related Markets Trend Analysis
4 GLOBAL IMMUNO-ONCOLOGY TREATMENT MARKET SIZE CATEGORIZED BY REGIONS
4.1 Global Immuno-Oncology Treatment Revenue and Market Share by Regions
4.1.1 Global Immuno-Oncology Treatment Sales and Market Share by Regions (2015-2020)
4.1.2 Global Immuno-Oncology Treatment Revenue and Market Share by Regions (2015-2020)
4.2 Europe Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
4.3 APAC Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
4.4 North America Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
4.5 South America Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
5 EUROPE IMMUNO-ONCOLOGY TREATMENT MARKET SIZE CATEGORIZED BY COUNTRIES
5.1 Europe Immuno-Oncology Treatment Revenue and Market Share by Countries
5.1.1 Europe Immuno-Oncology Treatment Revenue by Countries (2015-2020)
5.1.2 Germany Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
5.1.3 UK Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
5.1.4 France Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
5.1.5 Russia Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
5.1.6 Italy Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
5.1.7 Spain Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
5.2 Europe Immuno-Oncology Treatment Revenue (Value) by Manufacturers (2018-2020)
5.3 Europe Immuno-Oncology Treatment Revenue and Market Share by Type (2015-2020)
5.4 Europe Immuno-Oncology Treatment Revenue and Market Share by Application (2015-2020)
6 ASIA-PACIFIC IMMUNO-ONCOLOGY TREATMENT MARKET SIZE CATEGORIZED BY COUNTRIES
6.1 Asia-Pacific Immuno-Oncology Treatment Revenue and Market Share by Countries
6.1.1 Asia-Pacific Immuno-Oncology Treatment Revenue by Countries (2015-2020)
6.1.2 China Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
6.1.3 Japan Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
6.1.4 Korea Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
6.1.5 India Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
6.1.6 Southeast Asia Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
6.1.7 Australia Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
6.2 Asia-Pacific Immuno-Oncology Treatment Revenue (Value) by Players (2018-2020)
6.3 Asia-Pacific Immuno-Oncology Treatment Revenue and Market Share by Type (2015-2020)
6.4 Asia-Pacific Immuno-Oncology Treatment Revenue and Market Share by Application (2015-2020)
7 NORTH AMERICA IMMUNO-ONCOLOGY TREATMENT MARKET SIZE CATEGORIZED BY COUNTRIES
7.1 North America Immuno-Oncology Treatment Revenue and Market Share by Countries
7.1.1 North America Immuno-Oncology Treatment Revenue by Countries (2015-2020)
7.1.2 United States Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
7.1.3 Canada Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
7.1.4 Mexico Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
7.2 North America Immuno-Oncology Treatment Revenue (Value) by Players (2018-2020)
7.3 North America Immuno-Oncology Treatment Revenue and Market Share by Type (2015-2020)
7.4 North America Immuno-Oncology Treatment Revenue and Market Share by Application (2015-2020)
8 SOUTH AMERICA IMMUNO-ONCOLOGY TREATMENT MARKET SIZE CATEGORIZED BY COUNTRIES
8.1 South America Immuno-Oncology Treatment Revenue and Market Share by Countries
8.1.1 South America Immuno-Oncology Treatment Revenue by Countries (2015-2020)
8.1.2 Brazil Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
8.2 South America Immuno-Oncology Treatment Revenue (Value) by Players (2018-2020)
8.3 South America Immuno-Oncology Treatment Revenue and Market Share by Type (2015-2020)
8.4 South America Immuno-Oncology Treatment Revenue and Market Share by Application (2015-2020)
9 MIDDLE EAST AND AFRICA IMMUNO-ONCOLOGY TREATMENT MARKET SIZE CATEGORIZED BY COUNTRIES
9.1 Middle East and Africa Immuno-Oncology Treatment Revenue and Market Share by Countries
9.1.1 Middle East and Africa Immuno-Oncology Treatment Revenue by Countries (2015-2020)
9.1.2 GCC Countries Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
9.1.3 Turkey Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
9.1.4 Egypt Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
9.1.5 South Africa Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
9.2 Middle East and Africa Immuno-Oncology Treatment Revenue (Value) by Players (2018-2020)
9.3 Middle East and Africa Immuno-Oncology Treatment Revenue and Market Share by Type (2015-2020)
9.4 Middle East and Africa Immuno-Oncology Treatment Revenue and Market Share by Application (2015-2020)
10 GLOBAL IMMUNO-ONCOLOGY TREATMENT MARKET SEGMENT BY TYPE
10.1 Global Immuno-Oncology Treatment Revenue and Market Share by Type (2015-2020)
10.2 Global Immuno-Oncology Treatment Market Forecast by Type (2020-2025)
10.3 Immune Checkpoint Inhibitors Revenue Growth Rate
10.4 Monoclonal Antibodies Revenue Growth Rate
10.5 Cytokine-Based Immunotherapy Revenue Growth Rate
10.6 Cancer Vaccines Revenue Growth Rate
10.7 CAR-T Cell Therapy Revenue Growth Rate
11 GLOBAL IMMUNO-ONCOLOGY TREATMENT MARKET SEGMENT BY APPLICATION
11.1 Global Immuno-Oncology Treatment Revenue Market Share by Application (2015-2020)
11.2 Global Immuno-Oncology Treatment Market Forecast by Application (2020-2025)
11.3 Hospitals Revenue Growth Rate (2015-2025)
11.4 Ambulatory Surgical Center Revenue Growth Rate (2015-2025)
11.5 Others Revenue Growth Rate (2015-2025)
12 MARKET FORECAST FOR IMMUNO-ONCOLOGY TREATMENT
12.1 Global Immuno-Oncology Treatment Market Size Forecast (2020-2025)
12.2 Immuno-Oncology Treatment Market Forecast by Regions (2020-2025)
12.3 Europe Immuno-Oncology Treatment Revenue Market Forecast (2020-2025)
12.4 APAC Immuno-Oncology Treatment Revenue Market Forecast (2020-2025)
12.5 North America Immuno-Oncology Treatment Revenue Market Forecast (2020-2025)
12.6 South America Immuno-Oncology Treatment Revenue Market Forecast (2020-2025)
12.7 Middle East & Africa Immuno-Oncology Treatment Revenue Market Forecast (2020-2025)
13 ANALYSIS OF IMMUNO-ONCOLOGY TREATMENT INDUSTRY KEY VENDORS
13.1 Amgen
13.1.1 Company Details
13.1.2 Product Information
13.1.3 Amgen Immuno-Oncology Treatment Revenue and Gross Margin (2018-2020)
13.1.4 Main Business Overview
13.1.5 Amgen News
13.2 AstraZeneca
13.2.1 Company Details
13.2.2 Product Information
13.2.3 AstraZeneca Immuno-Oncology Treatment Revenue and Gross Margin (2018-2020)
13.2.4 Main Business Overview
13.2.5 AstraZeneca News
13.3 Bristol-Myers Squibb
13.3.1 Company Details
13.3.2 Product Information
13.3.3 Bristol-Myers Squibb Immuno-Oncology Treatment Revenue and Gross Margin (2018-2020)
13.3.4 Main Business Overview
13.3.5 Bristol-Myers Squibb News
13.4 Eli-Lilly
13.4.1 Company Details
13.4.2 Product Information
13.4.3 Eli-Lilly Immuno-Oncology Treatment Revenue and Gross Margin (2018-2020)
13.4.4 Main Business Overview
13.4.5 Eli-Lilly News
13.5 Roche
13.5.1 Company Details
13.5.2 Product Information
13.5.3 Roche Immuno-Oncology Treatment Revenue and Gross Margin (2018-2020)
13.5.4 Main Business Overview
13.5.5 Roche News
13.6 GlaxoSmithKline
13.6.1 Company Details
13.6.2 Product Information
13.6.3 GlaxoSmithKline Immuno-Oncology Treatment Revenue and Gross Margin (2018-2020)
13.6.4 Main Business Overview
13.6.5 GlaxoSmithKline News
13.7 Janssen Biotech
13.7.1 Company Details
13.7.2 Product Information
13.7.3 Janssen Biotech Immuno-Oncology Treatment Revenue and Gross Margin (2018-2020)
13.7.4 Main Business Overview
13.7.5 Janssen Biotech News
13.8 Merck
13.8.1 Company Details
13.8.2 Product Information
13.8.3 Merck Immuno-Oncology Treatment Revenue and Gross Margin (2018-2020)
13.8.4 Main Business Overview
13.8.5 Merck News
13.9 Novartis
13.9.1 Company Details
13.9.2 Product Information
13.9.3 Novartis Immuno-Oncology Treatment Revenue and Gross Margin (2018-2020)
13.9.4 Main Business Overview
13.9.5 Novartis News
13.10 Pfizer
13.10.1 Company Details
13.10.2 Product Information
13.10.3 Pfizer Immuno-Oncology Treatment Revenue and Gross Margin (2018-2020)
13.10.4 Main Business Overview
13.10.5 Pfizer News
13.11 Sanofi
13.11.1 Company Details
13.11.2 Product Information
13.11.3 Sanofi Immuno-Oncology Treatment Revenue and Gross Margin (2018-2020)
13.11.4 Main Business Overview
13.11.5 Sanofi News
13.12 Spectrum Pharmaceuticals
13.12.1 Company Details
13.12.2 Product Information
13.12.3 Spectrum Pharmaceuticals Immuno-Oncology Treatment Revenue and Gross Margin (2018-2020)
13.12.4 Main Business Overview
13.12.5 Spectrum Pharmaceuticals News
13.13 Takeda
13.13.1 Company Details
13.13.2 Product Information
13.13.3 Takeda Immuno-Oncology Treatment Revenue and Gross Margin (2018-2020)
13.13.4 Main Business Overview
13.13.5 Takeda News
14 RESEARCH FINDINGS AND CONCLUSION
15 APPENDIX
LIST OF TABLES AND FIGURES
Figure Immuno-Oncology Treatment Picture
Figure Research Programs/Design for This Report
Figure Global Immuno-Oncology Treatment Market by Regions (2019)
Table Global Market Immuno-Oncology Treatment Comparison by Regions (M USD) 2019-2025
Table Global Immuno-Oncology Treatment Value Growth (CAGR) (2019-2025) by Type
Figure Global Value Market Share of Immuno-Oncology Treatment by Type in 2019
Figure Immune Checkpoint Inhibitors Picture
Figure Monoclonal Antibodies Picture
Figure Cytokine-Based Immunotherapy Picture
Figure Cancer Vaccines Picture
Figure CAR-T Cell Therapy Picture
Table Global Immuno-Oncology Treatment Sales by Application (2019-2025)
Figure Global Immuno-Oncology Treatment Value Market Share by Application in 2019
Figure Hospitals Picture
Figure Ambulatory Surgical Center Picture
Figure Others Picture
Table Global Immuno-Oncology Treatment Revenue by Vendors (2018-2020)
Figure Global Immuno-Oncology Treatment Revenue Market Share by Vendors in 2019
Table Global Immuno-Oncology Treatment Vendors Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Immuno-Oncology Treatment Vendors (Revenue) Market Share in 2019
Figure Top 10 Immuno-Oncology Treatment Vendors (Revenue) Market Share in 2019
Table Date of Key Vendors Enter into Immuno-Oncology Treatment Market
Table Key Vendors Immuno-Oncology Treatment Product Type
Table Mergers & Acquisitions Planning
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Table Key Players of Related Markets
Figure Global Immuno-Oncology Treatment Revenue (Million USD) and Growth Rate (%) (2015-2020)
Table Global Immuno-Oncology Treatment Revenue (Million USD) by Regions (2015-2020)
Table Global Immuno-Oncology Treatment Revenue Market Share by Regions (2015-2020)
Figure Global Immuno-Oncology Treatment Revenue Market Share by Regions in 2019
Figure Europe Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
Figure APAC Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
Figure North America Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
Figure South America Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
Figure Middle East & Africa Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
Figure Europe Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
Table Europe Immuno-Oncology Treatment Revenue by Countries (2015-2020)
Table Europe Immuno-Oncology Treatment Revenue Market Share by Countries (2015-2020)
Figure Europe Immuno-Oncology Treatment Revenue Market Share by Countries in 2019
Figure Germany Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
Figure UK Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
Figure France Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
Figure Russia Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
Figure Italy Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
Figure Spain Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
Table Europe Immuno-Oncology Treatment Revenue by Player (2018-2020)
Figure Europe Immuno-Oncology Treatment Revenue Market Share by Player in 2019
Table Europe Immuno-Oncology Treatment Revenue by Type (2015-2020)
Table Europe Immuno-Oncology Treatment Revenue Share by Type (2015-2020)
Table Europe Immuno-Oncology Treatment Revenue by Application (2015-2020)
Table Europe Immuno-Oncology Treatment Revenue Share by Application (2015-2020)
Figure Asia-Pacific Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
Table Asia-Pacific Immuno-Oncology Treatment Revenue by Countries (2015-2020)
Table Asia-Pacific Immuno-Oncology Treatment Revenue Market Share by Countries (2015-2020)
Figure Asia-Pacific Immuno-Oncology Treatment Revenue Market Share by Countries (2015-2020)
Figure Asia-Pacific 138 Revenue Market Share by Countries in 2019
Figure China Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
Figure Japan Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
Figure Korea Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
Figure India Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
Figure Australia Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
Table Asia-Pacific Immuno-Oncology Treatment Revenue by Player (2018-2020)
Figure Asia-Pacific Immuno-Oncology Treatment Revenue Market Share by Player in 2019
Table Asia-Pacific Immuno-Oncology Treatment Revenue by Type (2015-2020)
Table Asia-Pacific Immuno-Oncology Treatment Revenue Share by Type (2015-2020)
Table Asia-Pacific Immuno-Oncology Treatment Revenue by Application (2015-2020)
Table Asia-Pacific Immuno-Oncology Treatment Revenue Share by Application (2015-2020)
Figure North America Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
Table North America Immuno-Oncology Treatment Revenue by Countries (2015-2020)
Table North America Immuno-Oncology Treatment Revenue Market Share by Countries (2015-2020)
Figure North America Immuno-Oncology Treatment Revenue Market Share by Countries in 2019
Figure United States Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
Figure Canada Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
Figure Mexico Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
Table North America Immuno-Oncology Treatment Revenue by Player (2018-2020)
Figure North America Immuno-Oncology Treatment Revenue Market Share by Player in 2019
Table North America Immuno-Oncology Treatment Revenue by Type (2015-2020)
Table North America Immuno-Oncology Treatment Revenue Share by Type (2015-2020)
Table North America Immuno-Oncology Treatment Revenue by Application (2015-2020)
Table North America Immuno-Oncology Treatment Revenue Share by Application (2015-2020)
Figure South America Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
Table South America Immuno-Oncology Treatment Revenue by Countries (2015-2020)
Table South America Immuno-Oncology Treatment Revenue Market Share by Countries (2015-2020)
Figure South America Immuno-Oncology Treatment Revenue Market Share by Countries in 2019
Figure Brazil Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
Table South America Immuno-Oncology Treatment Revenue by Player (2018-2020)
Figure South America Immuno-Oncology Treatment Revenue Market Share by Manufacturer in 2019
Table South America Immuno-Oncology Treatment Revenue by Type (2015-2020)
Table South America Immuno-Oncology Treatment Revenue Share by Type (2015-2020)
Table South America Immuno-Oncology Treatment Revenue by Application (2015-2020)
Table South America Immuno-Oncology Treatment Revenue Share by Application (2015-2020)
Figure Middle East and Africa Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
Table Middle East and Africa Immuno-Oncology Treatment Revenue by Countries (2015-2020)
Table Middle East and Africa Immuno-Oncology Treatment Revenue Market Share by Countries (2015-2020)
Figure Middle East and Africa Immuno-Oncology Treatment Sales Market Share by Countries in 2019
Figure Middle East and Africa Immuno-Oncology Treatment Revenue Market Share by Countries in 2019
Figure GCC Countries Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
Figure Egypt Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
Figure Turkey Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
Figure South Africa Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
Table Middle East and Africa Immuno-Oncology Treatment Revenue by Player (2018-2020)
Figure Middle East and Africa Immuno-Oncology Treatment Revenue Market Share by Player in 2019
Table Middle East and Africa Immuno-Oncology Treatment Revenue by Type (2015-2020)
Table Middle East and Africa Immuno-Oncology Treatment Revenue Share by Type (2015-2020)
Table Middle East and Africa Immuno-Oncology Treatment Revenue by Application (2015-2020)
Table Middle East and Africa Immuno-Oncology Treatment Revenue Share by Application (2015-2020)
Table Global Immuno-Oncology Treatment Revenue (Million USD) by Type (2015-2020)
Table Global Immuno-Oncology Treatment Revenue Share by Type (2015-2020)
Figure Global Immuno-Oncology Treatment Revenue Share by Type (2015-2020)
Figure Global Immuno-Oncology Treatment Revenue Share by Type in 2019
Table Global Immuno-Oncology Treatment Revenue Forecast by Type (2020-2025)
Figure Global Immuno-Oncology Treatment Market Share Forecast by Type (2020-2025)
Figure Global Immune Checkpoint Inhibitors Revenue Growth Rate (2015-2025)
Figure Global Monoclonal Antibodies Revenue Growth Rate (2015-2025)
Figure Global Cytokine-Based Immunotherapy Revenue Growth Rate (2015-2025)
Figure Global Cancer Vaccines Revenue Growth Rate (2015-2025)
Figure Global CAR-T Cell Therapy Revenue Growth Rate (2015-2025)
Table Global Immuno-Oncology Treatment Revenue by Application (2015-2020)
Table Global Immuno-Oncology Treatment Revenue Share by Application (2015-2020)
Figure Global Immuno-Oncology Treatment Revenue Share by Application (2015-2020)
Figure Global Immuno-Oncology Treatment Revenue Share by Application in 2019
Figure Global Immuno-Oncology Treatment Revenue Forecast by Application (2020-2025)
Figure Global Immuno-Oncology Treatment Market Share Forecast by Application (2020-2025)
Figure Global Hospitals Revenue Growth Rate (2015-2025)
Figure Global Ambulatory Surgical Center Revenue Growth Rate (2015-2025)
Figure Global Others Revenue Growth Rate (2015-2025)
Figure Global Immuno-Oncology Treatment Revenue (Million USD) and Growth Rate Forecast (2020-2025)
Figure Global Immuno-Oncology Treatment Revenue (Million USD) Forecast by Regions (2020-2025)
Figure Global Immuno-Oncology Treatment Revenue Market Share Forecast by Regions (2020-2025)
Figure Europe Immuno-Oncology Treatment Revenue Market Forecast (2020-2025)
Figure Asia-Pacific Immuno-Oncology Treatment Revenue Market Forecast (2020-2025)
Figure North America Immuno-Oncology Treatment Revenue Market Forecast (2020-2025)
Figure South America Immuno-Oncology Treatment Revenue Market Forecast (2020-2025)
Figure Middle East and Africa Immuno-Oncology Treatment Revenue Market Forecast (2020-2025)
Table Amgen Company Profile
Figure Immuno-Oncology Treatment Product Picture and Specifications of Amgen
Table Immuno-Oncology Treatment Revenue (M USD) and Gross Margin 2018-2020
Figure Amgen Immuno-Oncology Treatment Market Share (2018-2020)
Table Amgen Main Business
Table Amgen Recent Development
Table AstraZeneca Company Profile
Figure Immuno-Oncology Treatment Product Picture and Specifications of AstraZeneca
Table Immuno-Oncology Treatment Revenue (M USD) and Gross Margin 2018-2020
Figure AstraZeneca Immuno-Oncology Treatment Market Share (2018-2020)
Table AstraZeneca Main Business
Table AstraZeneca Recent Development
Table Bristol-Myers Squibb Company Profile
Figure Immuno-Oncology Treatment Product Picture and Specifications of Bristol-Myers Squibb
Table Immuno-Oncology Treatment Revenue (M USD) and Gross Margin 2018-2020
Figure Bristol-Myers Squibb Immuno-Oncology Treatment Market Share (2018-2020)
Table Bristol-Myers Squibb Main Business
Table Bristol-Myers Squibb Recent Development
Table Eli-Lilly Company Profile
Figure Immuno-Oncology Treatment Product Picture and Specifications of Eli-Lilly
Table Immuno-Oncology Treatment Revenue (M USD) and Gross Margin 2018-2020
Figure Eli-Lilly Immuno-Oncology Treatment Market Share (2018-2020)
Table Eli-Lilly Main Business
Table Eli-Lilly Recent Development
Table Roche Company Profile
Figure Immuno-Oncology Treatment Product Picture and Specifications of Roche
Table Immuno-Oncology Treatment Revenue (M USD) and Gross Margin 2018-2020
Figure Roche Immuno-Oncology Treatment Market Share (2018-2020)
Table Roche Main Business
Table Roche Recent Development
Table GlaxoSmithKline Company Profile
Figure Immuno-Oncology Treatment Product Picture and Specifications of GlaxoSmithKline
Table Immuno-Oncology Treatment Revenue (M USD) and Gross Margin 2018-2020
Figure GlaxoSmithKline Immuno-Oncology Treatment Market Share (2018-2020)
Table GlaxoSmithKline Main Business
Table GlaxoSmithKline Recent Development
Table Janssen Biotech Company Profile
Figure Immuno-Oncology Treatment Product Picture and Specifications of Janssen Biotech
Table Immuno-Oncology Treatment Revenue (M USD) and Gross Margin 2018-2020
Figure Janssen Biotech Immuno-Oncology Treatment Market Share (2018-2020)
Table Janssen Biotech Main Business
Table Janssen Biotech Recent Development
Table Merck Company Profile
Figure Immuno-Oncology Treatment Product Picture and Specifications of Merck
Table Immuno-Oncology Treatment Revenue (M USD) and Gross Margin 2018-2020
Figure Merck Immuno-Oncology Treatment Market Share (2018-2020)
Table Merck Main Business
Table Merck Recent Development
Table Novartis Company Profile
Figure Immuno-Oncology Treatment Product Picture and Specifications of Novartis
Table Immuno-Oncology Treatment Revenue (M USD) and Gross Margin 2018-2020
Figure Novartis Immuno-Oncology Treatment Market Share (2018-2020)
Table Novartis Main Business
Table Novartis Recent Development
Table Pfizer Company Profile
Figure Immuno-Oncology Treatment Product Picture and Specifications of Pfizer
Table Immuno-Oncology Treatment Revenue (M USD) and Gross Margin 2018-2020
Figure Pfizer Immuno-Oncology Treatment Market Share (2018-2020)
Table Pfizer Main Business
Table Pfizer Recent Development
Table Sanofi Company Profile
Figure Immuno-Oncology Treatment Product Picture and Specifications of Sanofi
Table Immuno-Oncology Treatment Revenue (M USD) and Gross Margin 2018-2020
Figure Sanofi Immuno-Oncology Treatment Market Share (2018-2020)
Table Sanofi Main Business
Table Sanofi Recent Development
Table Spectrum Pharmaceuticals Company Profile
Figure Immuno-Oncology Treatment Product Picture and Specifications of Spectrum Pharmaceuticals
Table Immuno-Oncology Treatment Revenue (M USD) and Gross Margin 2018-2020
Figure Spectrum Pharmaceuticals Immuno-Oncology Treatment Market Share (2018-2020)
Table Spectrum Pharmaceuticals Main Business
Table Spectrum Pharmaceuticals Recent Development
Table Takeda Company Profile
Figure Immuno-Oncology Treatment Product Picture and Specifications of Takeda
Table Immuno-Oncology Treatment Revenue (M USD) and Gross Margin 2018-2020
Figure Takeda Immuno-Oncology Treatment Market Share (2018-2020)
Table Takeda Main Business
Table Takeda Recent Development
Figure Immuno-Oncology Treatment Picture
Figure Research Programs/Design for This Report
Figure Global Immuno-Oncology Treatment Market by Regions (2019)
Table Global Market Immuno-Oncology Treatment Comparison by Regions (M USD) 2019-2025
Table Global Immuno-Oncology Treatment Value Growth (CAGR) (2019-2025) by Type
Figure Global Value Market Share of Immuno-Oncology Treatment by Type in 2019
Figure Immune Checkpoint Inhibitors Picture
Figure Monoclonal Antibodies Picture
Figure Cytokine-Based Immunotherapy Picture
Figure Cancer Vaccines Picture
Figure CAR-T Cell Therapy Picture
Table Global Immuno-Oncology Treatment Sales by Application (2019-2025)
Figure Global Immuno-Oncology Treatment Value Market Share by Application in 2019
Figure Hospitals Picture
Figure Ambulatory Surgical Center Picture
Figure Others Picture
Table Global Immuno-Oncology Treatment Revenue by Vendors (2018-2020)
Figure Global Immuno-Oncology Treatment Revenue Market Share by Vendors in 2019
Table Global Immuno-Oncology Treatment Vendors Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Immuno-Oncology Treatment Vendors (Revenue) Market Share in 2019
Figure Top 10 Immuno-Oncology Treatment Vendors (Revenue) Market Share in 2019
Table Date of Key Vendors Enter into Immuno-Oncology Treatment Market
Table Key Vendors Immuno-Oncology Treatment Product Type
Table Mergers & Acquisitions Planning
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Table Key Players of Related Markets
Figure Global Immuno-Oncology Treatment Revenue (Million USD) and Growth Rate (%) (2015-2020)
Table Global Immuno-Oncology Treatment Revenue (Million USD) by Regions (2015-2020)
Table Global Immuno-Oncology Treatment Revenue Market Share by Regions (2015-2020)
Figure Global Immuno-Oncology Treatment Revenue Market Share by Regions in 2019
Figure Europe Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
Figure APAC Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
Figure North America Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
Figure South America Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
Figure Middle East & Africa Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
Figure Europe Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
Table Europe Immuno-Oncology Treatment Revenue by Countries (2015-2020)
Table Europe Immuno-Oncology Treatment Revenue Market Share by Countries (2015-2020)
Figure Europe Immuno-Oncology Treatment Revenue Market Share by Countries in 2019
Figure Germany Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
Figure UK Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
Figure France Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
Figure Russia Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
Figure Italy Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
Figure Spain Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
Table Europe Immuno-Oncology Treatment Revenue by Player (2018-2020)
Figure Europe Immuno-Oncology Treatment Revenue Market Share by Player in 2019
Table Europe Immuno-Oncology Treatment Revenue by Type (2015-2020)
Table Europe Immuno-Oncology Treatment Revenue Share by Type (2015-2020)
Table Europe Immuno-Oncology Treatment Revenue by Application (2015-2020)
Table Europe Immuno-Oncology Treatment Revenue Share by Application (2015-2020)
Figure Asia-Pacific Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
Table Asia-Pacific Immuno-Oncology Treatment Revenue by Countries (2015-2020)
Table Asia-Pacific Immuno-Oncology Treatment Revenue Market Share by Countries (2015-2020)
Figure Asia-Pacific Immuno-Oncology Treatment Revenue Market Share by Countries (2015-2020)
Figure Asia-Pacific 138 Revenue Market Share by Countries in 2019
Figure China Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
Figure Japan Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
Figure Korea Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
Figure India Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
Figure Australia Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
Table Asia-Pacific Immuno-Oncology Treatment Revenue by Player (2018-2020)
Figure Asia-Pacific Immuno-Oncology Treatment Revenue Market Share by Player in 2019
Table Asia-Pacific Immuno-Oncology Treatment Revenue by Type (2015-2020)
Table Asia-Pacific Immuno-Oncology Treatment Revenue Share by Type (2015-2020)
Table Asia-Pacific Immuno-Oncology Treatment Revenue by Application (2015-2020)
Table Asia-Pacific Immuno-Oncology Treatment Revenue Share by Application (2015-2020)
Figure North America Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
Table North America Immuno-Oncology Treatment Revenue by Countries (2015-2020)
Table North America Immuno-Oncology Treatment Revenue Market Share by Countries (2015-2020)
Figure North America Immuno-Oncology Treatment Revenue Market Share by Countries in 2019
Figure United States Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
Figure Canada Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
Figure Mexico Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
Table North America Immuno-Oncology Treatment Revenue by Player (2018-2020)
Figure North America Immuno-Oncology Treatment Revenue Market Share by Player in 2019
Table North America Immuno-Oncology Treatment Revenue by Type (2015-2020)
Table North America Immuno-Oncology Treatment Revenue Share by Type (2015-2020)
Table North America Immuno-Oncology Treatment Revenue by Application (2015-2020)
Table North America Immuno-Oncology Treatment Revenue Share by Application (2015-2020)
Figure South America Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
Table South America Immuno-Oncology Treatment Revenue by Countries (2015-2020)
Table South America Immuno-Oncology Treatment Revenue Market Share by Countries (2015-2020)
Figure South America Immuno-Oncology Treatment Revenue Market Share by Countries in 2019
Figure Brazil Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
Table South America Immuno-Oncology Treatment Revenue by Player (2018-2020)
Figure South America Immuno-Oncology Treatment Revenue Market Share by Manufacturer in 2019
Table South America Immuno-Oncology Treatment Revenue by Type (2015-2020)
Table South America Immuno-Oncology Treatment Revenue Share by Type (2015-2020)
Table South America Immuno-Oncology Treatment Revenue by Application (2015-2020)
Table South America Immuno-Oncology Treatment Revenue Share by Application (2015-2020)
Figure Middle East and Africa Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
Table Middle East and Africa Immuno-Oncology Treatment Revenue by Countries (2015-2020)
Table Middle East and Africa Immuno-Oncology Treatment Revenue Market Share by Countries (2015-2020)
Figure Middle East and Africa Immuno-Oncology Treatment Sales Market Share by Countries in 2019
Figure Middle East and Africa Immuno-Oncology Treatment Revenue Market Share by Countries in 2019
Figure GCC Countries Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
Figure Egypt Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
Figure Turkey Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
Figure South Africa Immuno-Oncology Treatment Revenue and Growth Rate (2015-2020)
Table Middle East and Africa Immuno-Oncology Treatment Revenue by Player (2018-2020)
Figure Middle East and Africa Immuno-Oncology Treatment Revenue Market Share by Player in 2019
Table Middle East and Africa Immuno-Oncology Treatment Revenue by Type (2015-2020)
Table Middle East and Africa Immuno-Oncology Treatment Revenue Share by Type (2015-2020)
Table Middle East and Africa Immuno-Oncology Treatment Revenue by Application (2015-2020)
Table Middle East and Africa Immuno-Oncology Treatment Revenue Share by Application (2015-2020)
Table Global Immuno-Oncology Treatment Revenue (Million USD) by Type (2015-2020)
Table Global Immuno-Oncology Treatment Revenue Share by Type (2015-2020)
Figure Global Immuno-Oncology Treatment Revenue Share by Type (2015-2020)
Figure Global Immuno-Oncology Treatment Revenue Share by Type in 2019
Table Global Immuno-Oncology Treatment Revenue Forecast by Type (2020-2025)
Figure Global Immuno-Oncology Treatment Market Share Forecast by Type (2020-2025)
Figure Global Immune Checkpoint Inhibitors Revenue Growth Rate (2015-2025)
Figure Global Monoclonal Antibodies Revenue Growth Rate (2015-2025)
Figure Global Cytokine-Based Immunotherapy Revenue Growth Rate (2015-2025)
Figure Global Cancer Vaccines Revenue Growth Rate (2015-2025)
Figure Global CAR-T Cell Therapy Revenue Growth Rate (2015-2025)
Table Global Immuno-Oncology Treatment Revenue by Application (2015-2020)
Table Global Immuno-Oncology Treatment Revenue Share by Application (2015-2020)
Figure Global Immuno-Oncology Treatment Revenue Share by Application (2015-2020)
Figure Global Immuno-Oncology Treatment Revenue Share by Application in 2019
Figure Global Immuno-Oncology Treatment Revenue Forecast by Application (2020-2025)
Figure Global Immuno-Oncology Treatment Market Share Forecast by Application (2020-2025)
Figure Global Hospitals Revenue Growth Rate (2015-2025)
Figure Global Ambulatory Surgical Center Revenue Growth Rate (2015-2025)
Figure Global Others Revenue Growth Rate (2015-2025)
Figure Global Immuno-Oncology Treatment Revenue (Million USD) and Growth Rate Forecast (2020-2025)
Figure Global Immuno-Oncology Treatment Revenue (Million USD) Forecast by Regions (2020-2025)
Figure Global Immuno-Oncology Treatment Revenue Market Share Forecast by Regions (2020-2025)
Figure Europe Immuno-Oncology Treatment Revenue Market Forecast (2020-2025)
Figure Asia-Pacific Immuno-Oncology Treatment Revenue Market Forecast (2020-2025)
Figure North America Immuno-Oncology Treatment Revenue Market Forecast (2020-2025)
Figure South America Immuno-Oncology Treatment Revenue Market Forecast (2020-2025)
Figure Middle East and Africa Immuno-Oncology Treatment Revenue Market Forecast (2020-2025)
Table Amgen Company Profile
Figure Immuno-Oncology Treatment Product Picture and Specifications of Amgen
Table Immuno-Oncology Treatment Revenue (M USD) and Gross Margin 2018-2020
Figure Amgen Immuno-Oncology Treatment Market Share (2018-2020)
Table Amgen Main Business
Table Amgen Recent Development
Table AstraZeneca Company Profile
Figure Immuno-Oncology Treatment Product Picture and Specifications of AstraZeneca
Table Immuno-Oncology Treatment Revenue (M USD) and Gross Margin 2018-2020
Figure AstraZeneca Immuno-Oncology Treatment Market Share (2018-2020)
Table AstraZeneca Main Business
Table AstraZeneca Recent Development
Table Bristol-Myers Squibb Company Profile
Figure Immuno-Oncology Treatment Product Picture and Specifications of Bristol-Myers Squibb
Table Immuno-Oncology Treatment Revenue (M USD) and Gross Margin 2018-2020
Figure Bristol-Myers Squibb Immuno-Oncology Treatment Market Share (2018-2020)
Table Bristol-Myers Squibb Main Business
Table Bristol-Myers Squibb Recent Development
Table Eli-Lilly Company Profile
Figure Immuno-Oncology Treatment Product Picture and Specifications of Eli-Lilly
Table Immuno-Oncology Treatment Revenue (M USD) and Gross Margin 2018-2020
Figure Eli-Lilly Immuno-Oncology Treatment Market Share (2018-2020)
Table Eli-Lilly Main Business
Table Eli-Lilly Recent Development
Table Roche Company Profile
Figure Immuno-Oncology Treatment Product Picture and Specifications of Roche
Table Immuno-Oncology Treatment Revenue (M USD) and Gross Margin 2018-2020
Figure Roche Immuno-Oncology Treatment Market Share (2018-2020)
Table Roche Main Business
Table Roche Recent Development
Table GlaxoSmithKline Company Profile
Figure Immuno-Oncology Treatment Product Picture and Specifications of GlaxoSmithKline
Table Immuno-Oncology Treatment Revenue (M USD) and Gross Margin 2018-2020
Figure GlaxoSmithKline Immuno-Oncology Treatment Market Share (2018-2020)
Table GlaxoSmithKline Main Business
Table GlaxoSmithKline Recent Development
Table Janssen Biotech Company Profile
Figure Immuno-Oncology Treatment Product Picture and Specifications of Janssen Biotech
Table Immuno-Oncology Treatment Revenue (M USD) and Gross Margin 2018-2020
Figure Janssen Biotech Immuno-Oncology Treatment Market Share (2018-2020)
Table Janssen Biotech Main Business
Table Janssen Biotech Recent Development
Table Merck Company Profile
Figure Immuno-Oncology Treatment Product Picture and Specifications of Merck
Table Immuno-Oncology Treatment Revenue (M USD) and Gross Margin 2018-2020
Figure Merck Immuno-Oncology Treatment Market Share (2018-2020)
Table Merck Main Business
Table Merck Recent Development
Table Novartis Company Profile
Figure Immuno-Oncology Treatment Product Picture and Specifications of Novartis
Table Immuno-Oncology Treatment Revenue (M USD) and Gross Margin 2018-2020
Figure Novartis Immuno-Oncology Treatment Market Share (2018-2020)
Table Novartis Main Business
Table Novartis Recent Development
Table Pfizer Company Profile
Figure Immuno-Oncology Treatment Product Picture and Specifications of Pfizer
Table Immuno-Oncology Treatment Revenue (M USD) and Gross Margin 2018-2020
Figure Pfizer Immuno-Oncology Treatment Market Share (2018-2020)
Table Pfizer Main Business
Table Pfizer Recent Development
Table Sanofi Company Profile
Figure Immuno-Oncology Treatment Product Picture and Specifications of Sanofi
Table Immuno-Oncology Treatment Revenue (M USD) and Gross Margin 2018-2020
Figure Sanofi Immuno-Oncology Treatment Market Share (2018-2020)
Table Sanofi Main Business
Table Sanofi Recent Development
Table Spectrum Pharmaceuticals Company Profile
Figure Immuno-Oncology Treatment Product Picture and Specifications of Spectrum Pharmaceuticals
Table Immuno-Oncology Treatment Revenue (M USD) and Gross Margin 2018-2020
Figure Spectrum Pharmaceuticals Immuno-Oncology Treatment Market Share (2018-2020)
Table Spectrum Pharmaceuticals Main Business
Table Spectrum Pharmaceuticals Recent Development
Table Takeda Company Profile
Figure Immuno-Oncology Treatment Product Picture and Specifications of Takeda
Table Immuno-Oncology Treatment Revenue (M USD) and Gross Margin 2018-2020
Figure Takeda Immuno-Oncology Treatment Market Share (2018-2020)
Table Takeda Main Business
Table Takeda Recent Development
